Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
6
×
life sciences
6
×
national blog main
biotech
startups
vc
national top stories
boston blog main
boston top stories
healthcare
medical device
medical devices
medtech
new york blog main
new york top stories
san diego
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
abbott laboratories
acquisition
alivecor
allakos
alphabet
aperture venture partners
aphelion capital
arrythmia
ascension ventures
astrazeneca
azacitidine
bardy diagnostics
beta-thalassemia
boston
boston scientific
broad institute of harvard and mit
brook byers
cam
cambridge associates
What
based
6
×
developing
company
diagnostics
diego
medical
raised
san
startup
that’s
add
additional
aims
approach
arrhythmia
available
backing
bardy
big
bio
biosciences
biotech
business
called
capital
cardiac
carlsmed
cas
cheaper
cleveland
closes
crispr
deal
debuts
deerfield
detection
develop
device
domestic
drugs
Language
unset
unknown
Current search:
deals
×
based
×
" life sciences "
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Spine-Surgery Medtech Startup Carlsmed Merges With Imaging Company
@xconomy.com
5 years ago
Bardy Diagnostics to Ramp Up Cardiac Monitor Sales With $35M Raise
@xconomy.com
5 years ago
RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures
@xconomy.com
5 years ago
Shine Raises $30M, Could Add $150M More After Inking Deerfield Deal